Home / [018]
Companion app for GLP-1 weight-loss injections (dose reminders, drug concentration curves, photo-based protein estimates, weight charts), taken out of the US. Local-language versions that recognize local drug names and generics, subscription or one-time purchase. Brazil is validated; Taiwan, Korea, and Latin American Spanish-speaking markets are still open.
Open Trackable · regional expansion (health subscription) First seen 2026-11-01 · last updated 2026-11-07
- Status
- Open (5 already charting in Brazil's two storefronts; Taiwan, Korea and Spanish-speaking Latin America still open)
- Why now, and how long the window lasts
- Brazil cut prices after generic tirzepatide launched in year 2026, and users spread from the rich to the middle class. Monju's blurb name-checks Mounjaro, Ozempic, Wegovy, and local brands Tirzec, LipoLass, and "TG (tirzepatida genérica)". Every country that cuts GLP-1 prices repeats this, and the window follows each country's generics and insurance rules. Taiwan and Korea are happening now.
- Confidence
- 中高(巴西两端 5 家同时在榜,Monju 口碑 4.3–4.5 星);台湾、韩国的空位是推断。推翻条件:Monju 30 天内掉出巴西 H&F 畅销前 20;或 Shotsy、MeAgain 推出葡语、繁中、韩语版。
Evidence
Grouped by store. Each group starts with the charts that can be graphed (real curves, data dates below the chart), then the scanner's original notes and source links.
App Store3 evidence items · 5 products with curves
Monju: GLP-1 Tracker MG SOLUCOES DIGITAIS LTDA
App Store · Launched 2026-05-27 · Brazil rating 23,260 · 11-08 best overall Top Grossing rank #151 (Colombia) · Charted in 11-08 10 stores
BrazilColombiaUY
Data 2026-10-28 → 2026-11-08 (12 days, 12 observations). Lower rank is higher; gaps mean it wasn't charted that day
Data 2026-10-28 → 2026-11-08 (12 days, 12 observations)
OzemPro: Perder peso con GLP-1 FITCAL LTDA
App Store · launched 2025-10-08 · Brazil rating 18,115 · charted in 11-08 stores 23
BOVEBN
Data 2026-10-28 → 2026-11-07 (11 days, 6 observations). Lower rank is higher; gaps mean it wasn't charted that day
Data 2026-10-28 → 2026-11-07 (11 days, 6 observations)
Molife: a GLP-1 / GLP-1 weight-loss shot PEIYUN CHEN
App Store · launched 2026-07-08 · Taiwan rating 316 · charted in 11-08 stores · 2
TaiwanHong KongMO
Data 2026-10-28 → 2026-11-08 (12 days, 12 observations). Lower rank is higher; gaps mean it wasn't charted that day
Data 2026-10-28 → 2026-11-08 (12 days, 12 observations). Apple doesn't publish download counts; rating growth is a proxy for downloads.
App Store · launched 2025-09-24 · Taiwan rating 414 · charted in 11-08 stores · 1
TaiwanMOHong Kong
Data 2026-10-28 → 2026-11-08 (12 days, 12 observations). Lower rank is higher; gaps mean it wasn't charted that day
Data 2026-10-28 → 2026-11-08 (12 days, 12 observations). Apple doesn't publish download counts; rating growth is a proxy for downloads.
GLP1Suivi – Injections & poids Maximine
App Store · debuted 2026-02-25 · France ratings 559 · 11-07 charted in 1 stores
Data 2026-10-28 → 2026-11-07 (11 days, 10 observations). Lower rank is higher; gaps mean it wasn't charted that day
Data 2026-10-28 → 2026-11-07 (11 days, 10 observations). Apple doesn't publish download counts; rating growth is a proxy for downloads.
- App Store (br, 11-02): Monju: Emagrecer com GLP-1 (6761790660, MeuGuru, the developer's 3 apps, launched 2026-05-27), H&F Top Grossing #7; overall Top Grossing 10-28 #110 → 10-29 #121 → 10-30 #141 → 10-31 #161 → 11-01 dropped out of 200 → 11-02 back at #198; br rating 22,170, all-store total 24,144; average of written reviews 4.31 (reported). OzemPro (6753301974, FITCAL) br H&F Top Grossing #17,17,810 rating.
- App Store (Latin America, 11-02, H&F Top Grossing): Monju Spanish version uy #4 (overall Top Grossing #105,11-01 #127), pe #5 (overall #199), co #9, cl #13, mx #24 (11-01 #18); cr overall Top Grossing #196.
- App Store (tw / fr, 11-02, H&F Top Grossing): two Taiwanese indie developers' apps, Molife (launched 6776919333,7-08) #7, 299 rating; mojo (6751704399) #15, 388 rating (at report time, Top Free #22,11-01 and Top Grossing #36 only). French GLP1Suivi (6758305182) fr #181,541 rating.
Google Play2 evidence items · 5 products with curves
Monju: Lose Weight on GLP-1 Meu Guru
Google Play · Launched 2026-06-11 · 11-07 installs 156,787
Data 2026-10-29 → 2026-11-07 (10 days, 10 observations). Google's detail page only refreshes install counts every other day, so a flat day doesn't mean nobody installed.
Data 2026-10-29 → 2026-11-07 (10 days, 10 observations)
OzemPro: Lose Weight on GLP-1 FitCal LTDA
Google Play · Launched 2025-10-27 · 11-07 installs 192,622
Data 2026-10-29 → 2026-11-07 (10 days, 10 observations). Google's detail page only refreshes install counts every other day, so a flat day doesn't mean nobody installed.
Data 2026-10-29 → 2026-11-07 (10 days, 10 observations)
GLP-1 Control Glp1 Control
Google Play · Launched 2026-02-25 · 11-07 installs 92,607
Data 2026-10-29 → 2026-11-07 (10 days, 10 observations). Google's detail page only refreshes install counts every other day, so a flat day doesn't mean nobody installed.
Data 2026-10-29 → 2026-11-07 (10 days, 10 observations)
GLProgress GLProgress
Google Play · Launched 2026-07-13 · 11-07 installs 14,740
Data 2026-10-29 → 2026-11-07 (10 days, 7 observations). Google's detail page only refreshes install counts every other day, so a flat day doesn't mean nobody installed.
Mondiário: Health Diary Eduardo de Oliveira Freitas
Google Play · Launched 2026-06-02 · 11-07 installs 16,354
Data 2026-10-29 → 2026-11-07 (10 days, 10 observations). Google's detail page only refreshes install counts every other day, so a flat day doesn't mean nobody installed.
- Google Play (br, 11-02, H&F Top Grossing, 71 real local charts): Monju com.monju.app #7, overall Top Grossing #199 (11-01 #200), 148,212 installs, 19,727 ratings, Android rating count close to iOS Brazil; OzemPro com.segaritz.ozempro #9,187,800 installs; Mounjaro GLP-1 Controle com.glp1health.control (R$19.99 one-time purchase) #59,91,956 installs; GLProgress br.com.glpprogress.app #64 (not charted at report time); Mondiário com.ifitness.mondiario #72.
- Google Play (kr / us, 11-02): Korea's 삐약 com.vividHealth ("Korea's No. 1 Mounjaro / Wegovy log & community") Medical Free #16, 111,623 installs, not on any top chart. US comparison: Shotsy iOS 48,736 rating, Play 12,954; US users are on iPhone.
For sale listings 1 pieces of evidence · 1 products with curves
GlowAgain: GLP-1 Shot Tracker Promi LLC
App Store · launched 2025-11-04 · CR rating 1 · charted in 11-07 stores 1
Data 2026-11-04 → 2026-11-07 (4 days, 4 observations). Lower rank is higher; gaps mean it wasn't charted that day
Number of ratings 1
Data day 2026-11-02, only 1 days so far. Apple doesn't give download counts, so rating growth is the proxy
- For sale (Flippa, listed for 13885757,11-01 and unchanged for 11-02): GlowAgain: GLP-1 Shot Tracker (Singapore, 1 years old), monthly revenue $2,500, monthly profit $1,530,347 from subscriptions, asking $35,000, acquired via a TikTok creator funnel. Matches App Store id 6753928703 (Promi LLC); the library only charted it in cr, with 1 ratings. The English GLP-1 tracker was listed after reaching $2k MRR.
Meta Ad Library 1 evidence items · 1 products with curves
Tracky: GLP-1 Tracker DOFA TECH YAZILIM HIZMETLERI ANONIM SIRKETI
App Store · launched 2026-02-15 · Turkey rating 266 · charted in 11-08 stores 3
TurkeyHRAZ
Data 2026-10-28 → 2026-11-08 (12 days, 12 observations). Lower rank is higher; gaps mean it wasn't charted that day
Data 2026-10-28 → 2026-11-08 (12 days, 12 observations). Apple doesn't publish download counts; rating growth is a proxy for downloads.
- Meta Ad Library (11-02): searching GLP-1, software advertisers are only two English small accounts: "GLP-1 Tracker" (App Store 6758916201) running 13 ads, Ourax Apps (com.glpone.glp1tracker.weightloss) 27 ads; the rest are pharmacies and supplements. Monju and OzemPro are not in the library (English keywords, so Portuguese campaigns are not visible).
Already doing it
Brazil: Monju, OzemPro, GLP-1 Control, GLProgress, Mondiário; Taiwan: Molife, mojo; Korea: 삐약 (community-style, free); French: GLP1Suivi; US: Shotsy, MeAgain; English: GlowAgain (listed for sale).
The hardest step
Content and compliance, not technology. You have to know local drug names, dosage ladders, and generic strengths without giving medical advice. The only recurring Monju complaint is "says free but charges for everything".
Who it's for
Speakers of Portuguese / Spanish / Traditional Chinese / Korean / Japanese 1–2 people; build for both iOS and Android (Brazil's Android volume is no lower than iOS); subscription, or one-time purchase (GLP-1 Control at R$19.99 also charted). A meal-plan GLP-1 option is covered in [017], and the playbook is in [019].
Should every product builder know this?
No. But anyone in health should know the chain: "drug price cut → user base expands → local-language companion app needed".
Change log
2026-11-07
Codeway's Dosely is buying 120 → 93, and the same company's scanning app 79 → 31, both collecting within a week. A big player tested the waters and pulled back, so the local-language gap hasn't been taken yet.
2026-11-04
Big player entering: Codeway (a leading Turkish app factory, publisher DEEP FLOW SOFTWARE SERVICES) GLP-1 Tracker: Dosely (App Store 6787922283,8-13 launch, GP com.codeway.glpone) Page running 120 ads (passed the screen as "young apps buying ads"); App Store only 78 ratings, br Free category #131, not yet gaining traction. The same company this week is also scaling a new scanning app (22 → 79 ads). Codeway runs English and multilingual campaigns together, so watch whether it localizes into the local-language gaps (Taiwan, Korea, Latin America). Status unchanged; add to the disproof condition: Codeway's Dosely enters the Brazil H&F Top Grossing top 20.
2026-11-02
Backfill check: Monju's Brazil overall Top Grossing went from "dropped out of 200" back to #198; Play Brazil overall #200→#199; mojo entered Taiwan H&F Top Grossing #15; local GLP-1 apps on Play Brazil's H&F Top Grossing went from 4 to 5 (GLProgress entered #64).
2026-11-01
First recorded (backfill: from App Store New Opportunities §1.2, Google Play New Opportunities §1.3, Stringers §3.2, For Sale Listings §2.1; data as of 2026-11-01 / 11-02).
Original: Scanner opportunity library #018 (updated daily, 06:00); this page was generated on the 2026-11-08 edition.